RSS feed (help)
Notification
Search for previous notification documents
- Aripiprazole (Abilify) funding approved (2 pages, 85 KB) 11 Jul 2008
- Funding of levetiracetam approved (3 pages, 117 KB) 11 Jul 2008
- Tender results (5 pages, 116 KB) 01 Jul 2008
- Marquis condoms range increase (1 page, 147 KB) 25 Jun 2008
- Omeprazole sole supply start date delay (2 pages, 170 KB) 28 May 2008
- Varenicline, quinapril (2 pages, 121 KB) 23 May 2008
- Listing of Respigen (salbutamol 100 mcg aerosol inhaler) (3 pages, 168 KB) 21 Apr 2008
- Changed Close Control rules from 1 June 2008 (4 pages, 143 KB) 07 Mar 2008
Page updated on 11 Jul 2008
Linked documents
Aripiprazole (Abilify) funding approved (2 pages, 85 KB)
PHARMAC is pleased to announce the approval of funding for a new antipsychotic treatment, aripiprazole (Abilify), from 1 August 2008.
Please contact webmaster to discuss alternative format options.
Funding of levetiracetam approved (3 pages, 117 KB)
PHARMAC’s Board has approved the funding of the Keppra brand of the antiepilepsy agent levetiracetam for selected patients via a special access process, from 1 August 2008.
Please contact webmaster to discuss alternative format options.
Tender results (5 pages, 116 KB)
FAX Tender Results To: From: Date: All Suppliers and Wholesalers Yvonne Chen 30 June 2008 No of Pages (including this one): 5 Dear Supplier/Wholesaler TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders…
Marquis condoms range increase (1 page, 147 KB)
24 June 2008 Notification of Pharmaceutical Schedule changes Listing a wider range of Marquis brand condoms From 1 August 2008, a wider range of the Marquis brand of latex condoms will be listed in Section B of the Pharmaceutical Schedule.…
Omeprazole sole supply start date delay (2 pages, 170 KB)
Notification of Pharmaceutical Schedule Changes Further to our notification dated 7 April 2008 regarding the changes to the reimbursement of the heartburn and gastric ulcer treatment omeprazole, we wish to advise…
Varenicline, quinapril (2 pages, 121 KB)
23 May 2008 Pfizer agreement for varenicline, quinapril and medroxyprogesterone acetate not approved Summary The PHARMAC Board has not approved a provisional agreement with Pfizer New Zealand Limited, which was the subject of a consultation letter dated 30 November 2007.…
Listing of Respigen (salbutamol 100 mcg aerosol inhaler) (3 pages, 168 KB)
PHARMAC will be fully subsidising the Respigen brand of salbutamol asthma inhaler from 1 June 2008. Respigen is a CFC-free aerosol inhaler containing the asthma reliever drug salbutamol…
Changed Close Control rules from 1 June 2008 (4 pages, 143 KB)
Notification of changes to the Pharmaceutical Schedule Outline of the changes Close Control is a mechanism to permit subsidised medicines to be dispensed more frequently than the default period…
